China Isotope & Radiation Corporation (CIRC) filed its Monthly Return for the period ended 31 October 2026, confirming that both its authorised and issued share capital remained unchanged during the month.
Authorised / Registered Capital • H Shares: 79.97 million shares with a par value of RMB1 each, unchanged from September. • Domestic Shares: 239.91 million shares with a par value of RMB1 each, unchanged from September. • Total authorised share capital stood at RMB319.87 million.
Issued Shares and Public Float • H Shares in issue (excluding treasury shares) remained at 79.97 million; no treasury shares were held. • Domestic Shares in issue totalled 239.91 million; no treasury shares were held. • The company confirmed compliance with the Main Board’s minimum 25% public-float requirement for its H Share class.
Capital-Raising Instruments • The filing reports no activity in share options, warrants, convertibles or other equity-linked instruments during the month. • There were no Hong Kong Depositary Receipts outstanding or issued.
Governance Confirmation The submission, signed by Joint Company Secretary Ms Wang Cangren on 3 November 2026, attests that all regulatory and listing rule obligations were met and that there were no new issues, repurchases or cancellations requiring disclosure.
Overall, CIRC’s capital structure and share count were static through October 2026, reflecting a stable equity position with full adherence to Hong Kong Stock Exchange requirements.
Comments